"Alert fatigue is the greatest enemy of CDSS. Research reporting that clinicians override 49β96% of drug-safety alerts shows how serious the problem is."
β Drawing on van der Sijs et al., JAMIA 2006
Alert fatigue is the phenomenon in which an excessive number of alerts leads clinicians to ignore even important warnings.
| Indicator | Figure |
|---|---|
| Override rate of drug-safety alerts (systematic review) | 49β96% (van der Sijs et al., 2006) |
| Override rate of medication alerts in many individual studies | Commonly around 90% |
| Alerts per clinician per day | Varies widely by setting; frequently dozens |
| Alerts that are clinically meaningful | A small minority in many alert audits |
Do not present every alert the same way; differentiate by severity. WIA-MED-015 defines five alert levels (critical, high, medium, low, info). DDI severity from Chapter 4.2 maps onto them: contraindicated β critical, major β high, moderate β medium, minor β low or info.
| Severity | Presentation | User action |
|---|---|---|
| π¨ Critical | Interruptive, blocks the order Audible; not dismissible | Acknowledgement required (cancel / override with documented reason) |
| β οΈ High | Interruptive pop-up | Acknowledgement required (dismissible with reason; 5-min timeout) |
| β‘ Medium | Non-interruptive banner Shown for 30 seconds | Review recommended (dismissible) |
| πΉ Low | Non-interruptive Shown for 15 seconds | Optional review |
| βΉοΈ Info | Passive icon Shown for 10 seconds | No acknowledgement (details on click) |
Filter alerts by taking the patient and situational context into account.
Example: Warfarin-Aspirin interaction β Unconditional alert (bad): "Warfarin and Aspirin interaction warning" β the patient has already been taking both safely for a year β Context-aware (good): IF the patient has been on the combination for 3+ months AND no bleeding events AND INR stable THEN suppress the alert (or downgrade to informational) IF new prescription (combination just starting) THEN show a major warning
Concentrate on real clinical risk rather than theoretical interactions.
Principles:
- Filter along the scale "possible" < "probable" < "highly probable"
- DDIs supported only by isolated literature reports get low priority
- Emphasize only interactions with a high real-world rate of adverse events
Preventing the same alert from repeating: β Bad: On order entry: "DDI warning" On saving order: "DDI warning" (duplicate!) On signing order: "DDI warning" (duplicate again!!) β Good: On order entry: "DDI warning" (once only) Afterwards: the user has already acknowledged β no further alerts (re-warn only if there is a significant change)
Do not merely report the problem β provide a solution alongside it.
β Ineffective alert: βββββββββββββββββββββββββββββββ β β οΈ Drug interaction detected β β Warfarin + Aspirin β β [OK] β βββββββββββββββββββββββββββββββ β Effective alert: ββββββββββββββββββββββββββββββββββββββββββββββββ β β οΈ Warfarin + Aspirin interaction β β β β Risk: significantly increased bleeding β β β β π Recommended alternatives: β β [ Review antiplatelet need ] (1 click) β β [ Reduce aspirin dose ] (81 mg) β β β β π If combined, monitor: β β β’ INR twice a week β β β’ Watch for signs of bleeding β β β β [Choose alternative] [Approve] [Details] β ββββββββββββββββββββββββββββββββββββββββββββββββ
| Setting | Options |
|---|---|
| Alert sensitivity | Conservative / balanced / minimal |
| Specialty | Department-specific rules |
| Experience level | Resident / fellow / attending specialist |
| Alert display style | Pop-up / banner / icon |
Customization must never allow critical (contraindicated) alerts to be switched off; it adjusts presentation and lower-severity tiers only.
The CDSS learns clinicians' patterns and optimizes alerts:
| Metric | Target | Measurement |
|---|---|---|
| Acceptance rate | > 30% | Accepted / all alerts |
| Override rate | < 50% (certification) < 25% (operational) | Overridden / all alerts |
| Alert volume | < 15 per provider per 8-hour shift | Shift average |
| Critical-alert response time | < 5 minutes | Time from alert to acknowledgement |
| Missed-problem rate | < 1% | Real problems missed / total |
Acceptance and override thresholds follow the WIA-MED-015 specification; its integration phase sets the tighter operational override KPI and treats alerts overridden more than 50% of the time for three months or more as candidates for removal. The missed-problem rate is a recommended internal measure. The figures below are sample values illustrating how the dashboard is read, not measured results.
βββββββββββββββββββββββββββββββββββββββ Alert Performance Dashboard - January 2025 βββββββββββββββββββββββββββββββββββββββ Total alerts: 1,250 β Critical: 45 (3.6%) acceptance 95% β β οΈ High: 320 (25.6%) acceptance 42% β οΈ β‘ Medium: 580 (46.4%) acceptance 18% β βΉοΈ Info: 305 (24.4%) acceptance 8% βΉοΈ By alert type: Drug DDI: 850 override 62% β οΈ Allergy: 85 override 5% β Dose error: 120 override 15% β Duplicate therapy: 95 override 45% β οΈ Guideline: 100 override 78% β βββββββββββββββββββββββββββββββββββββββ Areas needing improvement: 1. Too many DDI alerts β re-calibrate severity 2. Guideline alerts β improve context 3. Medium severity β consider downgrading to low/info βββββββββββββββββββββββββββββββββββββββ
| Key point | Summary |
|---|---|
| Alert fatigue | 49β96% override rates reported; a serious safety threat |
| Tiering | Critical > high > medium > low > info |
| Optimization | Context awareness, clinical significance, alternatives |
| Customization | Physician preferences, learning-based improvement |
| Targets | Acceptance > 30%, override < 50% (operational < 25%) |
εΌηδΊΊι Β· Benefit All Humanity
Β© 2025 WIA - World Certification Industry Association